Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate China SXT Pharmaceuticals, Inc. before investing.

In this article, we go over a few key elements for understanding China SXT Pharmaceuticals, Inc.’s stock price such as:

• China SXT Pharmaceuticals, Inc.’s current stock price and volume
• Why China SXT Pharmaceuticals, Inc.’s stock price changed recently
• Upgrades and downgrades for SXTC from analysts
• SXTC’s stock price momentum as measured by its relative strength

About China SXT Pharmaceuticals, Inc. (SXTC)

Before we jump into China SXT Pharmaceuticals, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Want to learn more about China SXT Pharmaceuticals, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about China SXT Pharmaceuticals, Inc..

China SXT Pharmaceuticals, Inc.’s Stock Price as of Market Close

As of January 16, 2026, 4:00 PM, CST, China SXT Pharmaceuticals, Inc.’s stock price was $0.095.

China SXT Pharmaceuticals, Inc. is down 10.46% from its previous closing price of $0.106.

During the last market session, China SXT Pharmaceuticals, Inc.’s stock traded between $0.089 and $0.100. Currently, there are approximately 116.03 million shares outstanding for China SXT Pharmaceuticals, Inc..

China SXT Pharmaceuticals, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

China SXT Pharmaceuticals, Inc. Stock Price History

China SXT Pharmaceuticals, Inc.’s (SXTC) price is currently down 94.06% so far this month.

During the month of January, China SXT Pharmaceuticals, Inc.’s stock price has reached a high of $6.980 and a low of $0.089.

Over the last year, China SXT Pharmaceuticals, Inc. has hit prices as high as $7.840 and as low as $0.089. Year to date, China SXT Pharmaceuticals, Inc.’s stock is down 94.06%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused China SXT Pharmaceuticals, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of January 16, 2026, there were analysts who downgraded China SXT Pharmaceuticals, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate China SXT Pharmaceuticals, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on China SXT Pharmaceuticals, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

China SXT Pharmaceuticals, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about China SXT Pharmaceuticals, Inc. (SXTC) by visiting AAII Stock Evaluator.

Relative Price Strength of China SXT Pharmaceuticals, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 16, 2026, China SXT Pharmaceuticals, Inc. has a weighted four-quarter relative price strength of -53.80%, which translates to a Momentum Score of 1 and is considered to be Very Weak.

Want to learn more about how China SXT Pharmaceuticals, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

China SXT Pharmaceuticals, Inc. Stock Price: Bottom Line

As of January 16, 2026, China SXT Pharmaceuticals, Inc.’s stock price is $0.095, which is down 10.46% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like China SXT Pharmaceuticals, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.